Atomo Diagnostics (ASX:AT1) has received an AU$230,000 order from non-profit organization Thorne Harbour Health, to offer free HIV (human immunodeficiency virus) self-tests via vending machines across Australia, according to a Monday filing with the Australian bourse.
The company's HIV self-test has also been approved for sale in New Zealand, and will be launched this week through Chemist Warehouse, the filing said.
Shares of the company rose 13% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.